Neoadjuvant endocrine treatment in primary breast cancer – Review of literature
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference52 articles.
1. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group;Lancet Oncol,2008
2. Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomized controlled trial;Coombes;Lancet,2007
3. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98;Coates;J Clin Oncol,2007
4. Preoperative chemotherapy in patients with operable breast cancer: nine year results from national surgical adjuvant breast and bowel project B-18;Wolmark;J Natl Cancer Inst Monogr,2001
5. A reduction in requirements for mastectomy in a randomised trial of neoadjuvant chemoendocrine therapy in breast cancer;Makris;Ann Oncol,1998
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node‐Positive HR+, HER2− Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta‐Analysis;The Breast Journal;2024-01
2. Acute inflammatory response to multiple chemotherapy regimen in breast carcinoma: An unreported entity1;Breast Disease;2022-11-23
3. Morphological and molecular changes following neoadjuvant endocrine therapy of oestrogen receptor‐positive breast cancer: implications for clinical practice;Histopathology;2021-05-03
4. Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients;Breast Cancer Research and Treatment;2020-08-09
5. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study;Breast Cancer Research and Treatment;2020-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3